Karen Canfell
#90,525
Most Influential Person Now
Epidemiologist and cervical cancer researcher
Karen Canfell's AcademicInfluence.com Rankings
Karen Canfellmedical Degrees
Medical
#1552
World Rank
#1902
Historical Rank
Epidemiology
#710
World Rank
#738
Historical Rank
Download Badge
Medical
Why Is Karen Canfell Influential?
(Suggest an Edit or Addition)According to Wikipedia, Karen Canfell is an Australian epidemiologist and cancer researcher. After being awarded a D.Phil. from Oxford in 2004 with a thesis entitled Use of hormone replacement therapy as a potential co-factor in the neoplastic progression of HPV-related cervical disease, Canfell returned to Australia to work for the Cancer Council in Sydney where she continued to work on cervical cancer in particular and all its ramifications, as well as the epidemiology of breast, and other cancers.
Karen Canfell's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies (2012) (745)
- Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (2019) (350)
- Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries (2020) (291)
- Comprehensive control of human papillomavirus infections and related diseases. (2013) (247)
- The projected timeframe until cervical cancer elimination in Australia: a modelling study. (2018) (235)
- Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries (2020) (232)
- Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study. (2019) (231)
- Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models (2016) (199)
- The burden of cervical cancer in China: Synthesis of the evidence (2012) (138)
- Comprehensive control of human papillomavirus infections and related diseases. (2013) (134)
- The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. (2014) (133)
- Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program. (2017) (128)
- National Screening Committee’s criteria for appraising the viability, effectiveness and appropriateness of a screening programme (2014) (125)
- Modeling preventative strategies against human papillomavirus-related disease in developed countries. (2012) (116)
- Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women: Case–Control Study (2012) (110)
- Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality (2006) (110)
- Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies (2009) (107)
- The predicted effect of changes in cervical screening practice in the UK: results from a modelling study (2004) (106)
- Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study. (2020) (102)
- Towards the global elimination of cervical cancer (2019) (102)
- Cervical cancer screening in Middle Eastern and Asian migrants to Australia: a record linkage study. (2012) (99)
- Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study. (2017) (89)
- Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice (2017) (86)
- Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data. (2015) (86)
- Comprehensive control of human papillomavirus infections and related diseases. (2013) (77)
- Organic food consumption and the incidence of cancer in a large prospective study of women in the United Kingdom (2014) (75)
- Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases (2018) (75)
- Vulvar cancer in high‐income countries: Increasing burden of disease (2017) (74)
- Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial (2017) (74)
- Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study (2021) (72)
- 2020 List of human papillomavirus assays Suitable for primary cervical cancer screening. (2021) (71)
- Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. (2011) (71)
- Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool (2017) (69)
- The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia. (2011) (69)
- Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. (2009) (66)
- Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study (2011) (59)
- The predicted impact of vaccination on human papillomavirus infections in Australia (2008) (59)
- Health services costs for cancer care in Australia: Estimates from the 45 and Up Study (2018) (58)
- Will cervical screening remain cost‐effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries (2016) (58)
- A real time optoelectronic device as an adjunct to the Pap smear for cervical screening: A multicenter evaluation (2003) (57)
- Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia (2008) (56)
- Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia (2018) (54)
- Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. (2020) (52)
- Is it possible to halve the incidence of liver cancer in China by 2050? (2020) (51)
- Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand (2016) (51)
- The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000‐2011) (2016) (50)
- Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years (2010) (50)
- Impact of the Australian National Cervical Screening Program in women of different ages (2016) (49)
- Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: a micro-costing study (2012) (46)
- The impact of the Covid-19 pandemic on breast cancer early detection and screening (2021) (42)
- Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. (2019) (41)
- The IARC Perspective on Cervical Cancer Screening. (2021) (41)
- Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia Since 1982 (2015) (41)
- Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program (2014) (40)
- Projected time to elimination of cervical cancer in the USA: a comparative modelling study. (2020) (40)
- Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis. (2016) (39)
- Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study (2012) (39)
- Impact of HPV sample self‐collection for underscreened women in the renewed Cervical Screening Program (2016) (38)
- Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use (2016) (38)
- Anal cancer in high-income countries: Increasing burden of disease (2018) (37)
- Protocol and Rationale for the International Lung Screening Trial (2020) (35)
- Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003 (2009) (35)
- HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control (2019) (33)
- A Prospective Study of Health Conditions Related to Alcohol Consumption Cessation Among 97,852 Drinkers Aged 45 and Over in Australia (2019) (32)
- Psychosocial impact of COVID-19 on cancer patients, survivors, and carers in Australia: a real-time assessment of cancer support services (2021) (32)
- How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia. (2020) (32)
- Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000–2011 (2016) (32)
- Cancer care disruption and reorganisation during the COVID-19 pandemic in Australia: A patient, carer and healthcare worker perspective (2021) (31)
- Modeling the Adenoma and Serrated Pathway to Colorectal CAncer (ASCCA) (2014) (30)
- Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study (2017) (29)
- The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England (2013) (28)
- Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis. (2019) (27)
- Evaluation of the benefits, harms and cost‐effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia (2018) (27)
- Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer (2020) (26)
- Estimating the Cost‐Effectiveness of Lung Cancer Screening with Low‐Dose Computed Tomography for High‐Risk Smokers in Australia (2018) (26)
- Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality—Model-Based Exploration of the Serrated Pathway (2015) (26)
- National Cervical Screening Program Renewal: Effectiveness modelling and economic evaluation in the Australian setting (Assessment Report). (2013) (26)
- Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis (2021) (26)
- Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study. (2015) (25)
- Impact of COVID-19-related care disruptions on cervical cancer screening in the United States (2021) (24)
- How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country (2017) (24)
- Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort. (2018) (24)
- Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia (2017) (24)
- Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study (2016) (24)
- Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia (2018) (23)
- Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012) (2018) (23)
- Alcohol consumption, drinking patterns and cancer incidence in an Australian cohort of 226,162 participants aged 45 years and over (2020) (22)
- The Polarprobe--emerging technology for cervical cancer screening. (1998) (22)
- Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data (2015) (21)
- Statistical projection methods for lung cancer incidence and mortality: a systematic review (2019) (21)
- Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand (2013) (21)
- Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia (2018) (21)
- Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985–2013 in all women and in Māori women (2017) (21)
- Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening (2018) (20)
- Selection of high‐risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China (2020) (20)
- The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study (2020) (20)
- Eliminating Cervical Cancer: Progress and Challenges for High-income Countries. (2021) (20)
- Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis (2021) (20)
- The burden of cancer attributable to modifiable risk factors: the Australian cancer-PAF cohort consortium (2017) (20)
- Cancer incidence and mortality in people aged less than 75 years: changes in Australia over the period 1987-2007. (2013) (20)
- Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake (2014) (19)
- Expenditure and resource utilisation for cervical screening in Australia (2012) (19)
- Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. (2019) (19)
- Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia. (2019) (19)
- Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence (2020) (19)
- Past cervical intraepithelial neoplasia grade 3, obesity, and earlier menopause are associated with an increased risk of vulval cancer in postmenopausal women (2016) (18)
- Cancer incidence and cancer death in relation to tobacco smoking in a population‐based Australian cohort study (2021) (18)
- Testing previous model predictions against new data on human papillomavirus vaccination program outcomes (2014) (18)
- Lung cancer mortality in Australia: Projected outcomes to 2040. (2018) (18)
- Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30-44 years: A case-control study in New South Wales, Australia. (2018) (18)
- Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled Analysis (2020) (17)
- The predicted impact and cost‐effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome (2019) (17)
- Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia (2012) (16)
- Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control? (2019) (16)
- The molecular characteristics of colonic neoplasms in serrated polyposis: a systematic review and meta‐analysis (2016) (16)
- Human Papillomavirus and Oropharyngeal Cancer Among Indigenous Australians: Protocol for a Prevalence Study of Oral-Related Human Papillomavirus and Cost-Effectiveness of Prevention (2018) (15)
- Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis (2022) (15)
- Patterns of care and emergency presentations for people with non-small cell lung cancer in New South Wales, Australia: A population-based study. (2018) (15)
- Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study (2018) (15)
- Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia. (2019) (14)
- A revision of sexual mixing matrices in models of sexually transmitted infection (2012) (14)
- Effect of changes in treatment practice on survival for cervical cancer: results from a population-based study in Manitoba, Canada (2015) (14)
- The burden of cervical cancer in Vietnam: Synthesis of the evidence. (2019) (14)
- Factors predicting successful DNA recovery from archival cervical smear samples (2004) (14)
- Using probabilistic record linkage methods to identify Australian Indigenous women on the Queensland Pap Smear Register: the National Indigenous Cervical Screening Project (2016) (14)
- Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible (2010) (13)
- Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model. (2013) (13)
- Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia (2017) (13)
- Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study (2022) (13)
- A survey of population-based utility scores for cervical cancer prevention (2014) (13)
- Evaluating prognostic factors for sex differences in lung cancer survival: findings from a large Australian cohort. (2022) (13)
- Eliminating cervical cancer in the COVID-19 era (2021) (13)
- Prevalence of Oral Human Papillomavirus Infection Among Australian Indigenous Adults (2020) (12)
- Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment (2020) (12)
- The agreement between self-reported cervical smear abnormalities and screening programme records (2006) (12)
- Has Human Papillomavirus (HPV) Vaccination Prevented Adverse Pregnancy Outcomes? Population-Level Analysis After 8 Years of a National HPV Vaccination Program in Australia. (2020) (12)
- Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. (2020) (12)
- Models of cervical screening in the era of human papillomavirus vaccination. (2010) (12)
- Comprehensive control of human papillomavirus infections and related diseases. (2013) (11)
- Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study (2014) (11)
- The future burden of lung cancer attributable to current modifiable behaviours: a pooled study of seven Australian cohorts. (2018) (11)
- Global cancer research in the era of COVID-19: a bibliometric analysis (2021) (11)
- Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol (2019) (11)
- National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study (2022) (11)
- Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities. (2015) (11)
- Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions (2019) (10)
- The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort study (2019) (10)
- HRT and Breast Cancer: Recent Findings in the Context of the Evidence to Date (2008) (10)
- Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis. (2022) (10)
- The future burden of kidney and bladder cancers preventable by behavior modification in Australia: A pooled cohort study (2020) (10)
- An epidemiological overview of the relationship between hormone replacement therapy and breast cancer (2011) (10)
- The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study. (2019) (10)
- The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications. (2019) (9)
- Normal endometrial cells in cervical cytology: systematic review of prevalence and relation to significant endometrial pathology (2008) (9)
- Prevalence of skin examination behaviours among Australians over time. (2020) (8)
- Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study (2018) (8)
- Health services costs for lung cancer care in Australia: Estimates from the 45 and Up Study (2020) (8)
- Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand. (2018) (8)
- Time to clinical investigation for Indigenous and non‐Indigenous Queensland women after a high grade abnormal Pap smear, 2000–2009 (2017) (8)
- Participation in cervical screening by older asian and middle eastern migrants in new South wales, australia. (2012) (8)
- Cervical screening in HPV-vaccinated populations (2018) (8)
- Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study (2016) (8)
- Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials (2020) (8)
- The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort Study (2018) (8)
- Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study (2020) (8)
- National Cervical Screening Programme Annual Report 2013 (2016) (8)
- Modeling Preventative Strategies against HPV-Related Disease in Developed Countries (2013) (7)
- The Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): Rationale and design of an unmatched "case-spouse control" study of over 10,000 participants in New South Wales, Australia. (2015) (7)
- Who should be vaccinated against HPV? (2015) (7)
- Resilience of a FIT screening programme against screening fatigue: a modelling study (2016) (7)
- Monitoring HPV vaccination programmes (2010) (7)
- Trends in Prescribing Menopausal Hormone Therapy and Bisphosphonates in Australia and Manitoba, Canada and Adherence to Recommendations. (2019) (7)
- A new era for cervical screening in Australia: Watch this space! (2017) (7)
- Cohort profile: indigenous human papillomavirus and oropharyngeal squamous cell carcinoma study - a prospective longitudinal cohort (2021) (7)
- HPV vaccine: uptake and understanding among global Indigenous communities – a qualitative systematic review (2021) (7)
- Development of a quality framework for models of cervical screening and its application to evaluations of the cost-effectiveness of HPV vaccination in developed countries. (2015) (7)
- Prospects for cost-effective lung cancer screening using risk calculators (2019) (6)
- Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study (2021) (6)
- Cost-Effectiveness of Proposed Changes to the National Cervical Screening Programme. Report to the NZ National Screening Unit (Commissioned Report) (2010) (6)
- Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations (2017) (6)
- Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient? (2021) (6)
- HPV vaccination and pregnancy (2015) (6)
- The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support (2021) (6)
- Pre-vaccination type-specific HPV prevalence in confirmed cervical high grade lesions in the Māori and non-Māori populations in New Zealand (2015) (5)
- The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study. (2022) (5)
- High‐grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: A cohort study with 10 years of follow‐up (2014) (5)
- HPV swab self‐collection and cervical cancer in women who have sex with women (2020) (5)
- Spatial variation in cervical cancer screening participation and outcomes among Indigenous and non-Indigenous Australians in Queensland (2019) (5)
- Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea (2022) (5)
- Socioeconomic disparities in colorectal cancer survival: contributions of prognostic factors in a large Australian cohort (2021) (5)
- Lung cancer treatment patterns and factors relating to systemic therapy use in Australia (2021) (5)
- National Cervical Screening Programme Monitoring Report 43 (1 January – 30 June 2015). Wellington: NZ Ministry of Health (2016) (5)
- Risk of childhood mortality associated with death of a mother in low-and-middle-income countries: a systematic review and meta-analysis (2019) (5)
- Health economic evaluation of primary human papillomavirus screening in urban populations in China. (2020) (5)
- Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres (2020) (5)
- Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England (2019) (5)
- Point-of-care HPV DNA testing of self-collected specimens and same-day thermal ablation for the early detection and treatment of cervical pre-cancer in women in Papua New Guinea: a prospective, single-arm intervention trial (HPV-STAT). (2022) (5)
- Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods. (2022) (4)
- Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia (2020) (4)
- Working towards a comprehensive understanding of HPV and cervical cancer among Indigenous women: a qualitative systematic review (2021) (4)
- Large-scale systematic analysis of exposure to multiple cancer risk factors and the associations between exposure patterns and cancer incidence (2021) (4)
- Real‐Time Devices for the Screening and Diagnosis of Cervical Neoplasia (2009) (4)
- Psychometric properties of the EQ-5D-5L for aboriginal Australians: a multi-method study (2021) (4)
- Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia (2021) (4)
- A systematic review and meta-analysis of the prevalence of human papillomavirus infection in Indigenous populations - A Global Picture. (2021) (4)
- Development and application of a framework to estimate health care costs in China: The cervical cancer example (2019) (4)
- School-Level Variation in Coverage of Co-Administered dTpa and HPV Dose 1 in Three Australian States (2021) (4)
- Self‐collection for HPV screening: a game changer in the elimination of cervical cancer (2021) (4)
- COVID-19 vaccination in patients with cancer, a rapid review (2022) (4)
- A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours (2022) (4)
- Treatment abandonment in children with cancer: Does a sex difference exist? A systematic review and meta‐analysis of evidence from low‐ and middle‐income countries (2020) (4)
- Workforce participation in relation to cancer diagnosis, type and stage: Australian population-based study of 163,556 middle-aged people (2021) (4)
- The burden of pancreatic cancer in Australia attributable to smoking (2019) (4)
- Progress in cancer screening: Where are we in 2014? (2014) (3)
- Changes in cancer incidence and mortality in Australia over the period 1996–2015 (2020) (3)
- Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening. (2022) (3)
- Solid Fuel, Secondhand Smoke, and Lung Cancer Mortality: A Prospective Cohort of 323,794 Chinese Never-Smokers (2022) (3)
- The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology (2020) (3)
- Guidelines for the economic analysis (2014) (3)
- Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence (2022) (3)
- Birth-cohort estimates of smoking initiation and prevalence in 20th century Australia: Synthesis of data from 33 surveys and 385,810 participants (2021) (3)
- Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study (2021) (3)
- Thyroid cancers potentially preventable by reducing overweight and obesity in Australia: A pooled cohort study (2021) (3)
- Modelling the Adenoma and Serrated Pathway to Colorectal Cancer (ASCCA) (2013) (3)
- HPV screening for cervical cancer is reaching maturity (2022) (3)
- An ecological study of obesity-related cancer incidence trends in Australia from 1983 to 2017 (2022) (3)
- Accurate categorisation of menopausal status for research studies: a step-by-step guide and detailed algorithm considering age, self-reported menopause and factors potentially masking the occurrence of menopause (2022) (2)
- Identifying incident cancer cases in routinely collected hospital data: a retrospective validation study (2019) (2)
- The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome. (2022) (2)
- Uptake of liquid-based cytology as an adjunct to conventional cytology for cervical screening in NSW, Australia: a cross-sectional and population-based cohort analysis (2013) (2)
- Large-Scale Population-Based Surveys Linked to Administrative Health Databases as a Source of Data on Health Utilities in Australia. (2022) (2)
- Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals (2022) (2)
- Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control (2021) (2)
- Oral contraceptives and hormone replacement therapy, and cancers of the female reproductive system (2010) (2)
- Moving beyond the stage: how characteristics at diagnosis dictate treatment and treatment-related quality of life year losses for women with early stage invasive breast cancer (2020) (2)
- Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040 (2022) (2)
- Correction: Anal cancer in high-income countries: Increasing burden of disease (2019) (2)
- Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China (2023) (2)
- The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes (2021) (2)
- What would I do? Perspectives on the factors underlying Lynch syndrome genetic testing and results sharing decisions for high‐risk colorectal cancer patients (2021) (2)
- Progress in eliminating HPV-associated disease (2019) (2)
- Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia (2009) (2)
- PROTOCOL FOR THE INTERNATIONAL LUNG SCREEN TRIAL (ILST): A COHORT STUDY TO DEFINE LDCT SCREENING SELECTION CRITERIA AND VALIDATE THE PANCAN NODULE MANAGEMENT ALGORITHM (2017) (2)
- ESTIMATING THE BENEFITS AND HARMS OF PSA TESTING IN THE AUSTRALIAN CONTEXT (2014) (2)
- Impact of Scaled up Human Papillomavirus Vaccination and Cervical Screening and the Potential for Global Elimination of Cervical Cancer in 181 Countries, 2020–99: A Modelling Study (2019) (2)
- Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian states. (2021) (2)
- Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia (2012) (1)
- 1343A systematic review and meta-analysis of tobacco smoking behaviour changes during the COVID-19 pandemic (2021) (1)
- Factors associated with prostate specific antigen testing in Australians: Analysis of the New South Wales 45 and Up Study (2018) (1)
- Health utilities for non‐melanoma skin cancers and pre‐cancerous lesions: A systematic review (2021) (1)
- Alcohol consumption, drinking patterns and cancer incidence in an Australian cohort of 226,162 participants aged 45 years and over (2020) (1)
- A Large Linked Study to Evaluate the Future Burden of Cancer in Australia Attributable to Current Modifiable Behaviours (2018) (1)
- COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies (2022) (1)
- Future Burden of Cancer Attributable to Current Modifiable Behaviours: A Pooled Study of Seven Australian Cohorts (2018) (1)
- Towards global elimination of cervical cancer in all groups of women - Authors' reply. (2019) (1)
- Testing previous model predictions against new data on human papillomavirus vaccination program outcomes (2014) (1)
- Evaluating risk factors for lung cancer among never-smoking individuals using two Australian studies (2022) (1)
- The health and economic impact of implementation strategies for improving detection of hereditary cancer patients—protocol for an in-depth cost-effectiveness evaluation with microsimulation modelling (2020) (1)
- The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence (2022) (1)
- Abstract 2285: Menopausal hormone therapy (MHT) use and breast cancer risk by receptor subtypes: results from the New South Wales Cancer Lifestyle and EvAluation of Risk (CLEAR) study (2017) (1)
- Inaccurate and fundamentally flawed analysis risks undermining confidence in cervical screening programs. (2018) (1)
- 1235Household air pollution and lung cancer mortality among never-smokers: findings from the China Kadoorie Biobank (2021) (1)
- Cost-effectiveness estimates: the need for complete reporting - Authors' reply. (2017) (1)
- Reflecting on the '45 and Up Study' after 15 years: learnings, impact and future opportunities from a large-scale cohort study. (2022) (1)
- Bayesian calibration of simulation models: A tutorial and an Australian smoking behaviour model (2022) (1)
- The Future Burden of Head and Neck Cancers Attributable to Modifiable Behaviors in Australia: A Pooled Cohort Study (2021) (1)
- Poor self-rated oral health associated with poorer general health among Indigenous Australians (2021) (1)
- High-Risk Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma Among Non-Indigenous and Indigenous Populations: A Systematic Review (2020) (1)
- Population-based utility scores for HPV infection and oropharyngeal squamous cell carcinoma among Indigenous Australians (2021) (1)
- The financial impact of a breast cancer detected within and outside of screening: lessons from the Australian Lifepool cohort (2020) (1)
- Measuring school level attributable risk to support school-based HPV vaccination programs (2022) (1)
- Is Cervix Cancer a Disappearing Disease? Impact of HPV Vaccination in Developed Countries (2014) (1)
- A systematic review and meta-analysis of tobacco smoking behaviour changes during the COVID-19 pandemic (2021) (1)
- How Well Have Projected Lung Cancer Rates Predicted the Actual Observed Rates? (2021) (1)
- A hepatitis B vaccine booster shot at age 10 could be cost-saving in China: But is it too soon to tell? (2019) (1)
- Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022. (2022) (1)
- The State of Cancer Control in Australia 1987-2007: Changes in cancer incidence and mortality (2013) (1)
- Impact of a human papillomavirus vaccination programme within organized cervical cancer screening: cohort study. (2022) (1)
- A survey of population-based utility scores for cervical cancer prevention (2014) (1)
- Cancer costs and gender: a snapshot of issues, trends, and opportunities to reduce inequities using Australia as an example (2019) (1)
- National Screening Unit Strategic Plan 2010 to 2015 (2010) (1)
- HPV vaccination of boys and girls beneficial (2015) (0)
- Sa1163 Modelling the Adenoma and Serrated Pathway to Colorectal Cancer (ASCCA) (2013) (0)
- The 'hot zone policy' for colorectal cancer screening presents unique risks and opportunities for rural Australia. (2023) (0)
- The State of Cancer Control Summary (2013) (0)
- The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England (2013) (0)
- Compliance with screening and management recommendations (2014) (0)
- Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours (2023) (0)
- Global prevention and management of HPV related diseases : the pressing challenges and the compelling opportunities (2014) (0)
- Projections of smoking-related cancer mortality in Australia to 2044 (2022) (0)
- Type-specific cumulative incidence supplementary tables (2014) (0)
- The impact of COVID-19-related disruptions to HPV vaccination - a modelled analysis (2023) (0)
- The Key Role of Mathematical Modeling and Health Economics in the Public Health Transitions in Cervical Cancer Prevention (2020) (0)
- MA11.03 Updated Cost-Effectiveness Analysis of Lung Cancer Screening for Australia, Capturing Differences in the Impact of NELSON and NLST Outcomes (2022) (0)
- Effect of changes in treatment practice on survival for cervical cancer: results from a population-based study in Manitoba, Canada (2015) (0)
- Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women (2021) (0)
- Key tables reproduced using the second definition of round 3 (2014) (0)
- A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia (2023) (0)
- Management of intermediate risk women after primary HPV testing for cervical screening : Evaluation of optimal management strategies for the National Cervical Screening Program in Australia (2016) (0)
- Economic Evaluation of the impact of HPV Vaccination on Cervical Screening in New Zealand. Report to the NZ National Screening Unit (Commissioned report) (2009) (0)
- Sexual behaviour data for the population model (2014) (0)
- 863Alcohol and cancer in an Australian cohort of 226,162 participants aged 45 years and over (2021) (0)
- 424Person-centred outcomes among 22,205 cancer survivors and 244,000 people without cancer: a population-based Australian study (2021) (0)
- Special Issue Papillomavirus Research: Editors Peter L Stern & Karen Canfell. (2019) (0)
- Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions. (2022) (0)
- Patient information sheet: Stockport primary care trust (2014) (0)
- A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: The Lung cancer Evaluation And Policy program (LEAPp) (2023) (0)
- The CLEAR Initiative - a Cancer Biobank for NSW (2006) (0)
- Screening and diagnostic test characteristics (2014) (0)
- How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia. (Special Issue: Extreme events: how do public health systems learn and adapt?) (2020) (0)
- 965The estimated impact of improved breast screening tests targeted at women with dense breasts (2021) (0)
- Long-Term Impact of the Dutch Colorectal Cancer Screening Programme on Cancer Incidence: Exploration of the Serrated Pathway. (2014) (0)
- Quality-adjusted life-year weights (2014) (0)
- P1.08-01 Updated Costs and Survival Expectations for Stage IV Lung Cancer in Australia (2022) (0)
- 704The preventable future burden of cancer in Australia (2021) (0)
- Capacity of the 45 and Up Study to mobilise evidence-based improvements in cancer control: lung cancer case study. (2022) (0)
- Aboriginal women have a higher risk of cervical abnormalities at screening; South Australia, 1993–2016 (2018) (0)
- ' s response to reviews Title : Uptake of Liquid-Based Cytology as an adjunct to conventional cytology for cervical screening in NSW : A cross-sectional and population-based cohort analysis (2013) (0)
- Colonoscopies in Australia - how much does the National Bowel Cancer Screening Program contribute to colonoscopy use? (2022) (0)
- Hormone replacement therapy and breast cancer: recent results in the context of the evidence to date (2008) (0)
- Overdiagnosis of screen‐detected breast cancer (2021) (0)
- P3.06-008 Lung Cancer Pathways: A Five-Year Program to Reduce Impact Through Epidemiological Modelling and Investment in Prioritized Interventions (2017) (0)
- Reflections from field notes: An oral human papillomavirus infection and oropharyngeal cancer study among Indigenous Australians. (2022) (0)
- Model predictions of the ARTISTIC trial (2014) (0)
- Oral HPV infection among Indigenous Australians; incidence, persistence and clearance at 12-months follow-up. (2021) (0)
- 656Risk factors for lung cancer in never-smokers in Australia (2021) (0)
- PapilloCheck® human papillomavirus genotyping (2014) (0)
- The impact of COVID-19 on population cancer screening programs in Australia: modelled evaluations for breast, bowel and cervical cancer (2022) (0)
- Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia. (2022) (0)
- Identifying incident cancer cases in routinely collected hospital data: a retrospective validation study (2019) (0)
- Health impacts of COVID-19 disruptions to primary cervical screening by time since last screen: A model-based analysis for current and future disruptions (2022) (0)
- Opportunities and challenges for implementation of cost-effective lung cancer screening (2019) (0)
- Economic impact of using risk models for eligibility selection to the International lung screening Trial. (2022) (0)
- Global and regional estimates of orphans attributed to maternal cancer mortality in 2020 (2022) (0)
- Comparison of risk factors for cirrhosis and hepatocellular carcinoma: a large prospective study of UK women (2020) (0)
- Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening (2023) (0)
- Female reproductive and hormonal factors and lung cancer mortality among never‐smokers: A prospective cohort study of 287 408 Chinese women (2023) (0)
- Sexual Behavior, HPV Status and P16 Expression in Oropharyngeal and Oral Cavity Squamous Cell Carcinoma Patients (2017) (0)
- Cancer elimination thresholds: one size does not fit all - Authors' reply. (2019) (0)
- Reduction in Domestic HPV Vaccine Price Enables Good Economic Returns for Cervical Cancer Prevention in China: A Cost-Effectiveness Analysis (2019) (0)
- OP-IJEJ210168_5 205..205 ++ (2021) (0)
- Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985–2013 in all women and in Māori women (2017) (0)
- Abstract 2279: Burden of colorectal cancer attributable to lifestyle-related risk factors: a pooled study of seven Australian cohorts (2017) (0)
- TABLE 82, [Modelled inadequate rate of HPV test]. (2014) (0)
- Patient information sheet: Manchester, Salford, Trafford and Ashton, Leigh & Wigan primary care trusts (2014) (0)
- The ICCon familial cancer database (2018) (0)
- 783 IMPACT OF COVID-19 RELATED DISRUPTIONS TO COLORECTAL CANCER SCREENING PROGRAMS IN THREE COUNTRIES: A COMPARATIVE MODELLING STUDY (2021) (0)
- Changes to the cervical cancer screening program in Australia (2016) (0)
- Erratum to: The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England (2013) (0)
- Determining the test probability matrices for liquid-based cytology in ARTISTIC (2014) (0)
- An intelligent cardio-synchronous myostimulator (1993) (0)
- Raking of data from a large Australian cohort study improves generalisability of estimates of prevalence of health and behaviour characteristics and cancer incidence (2022) (0)
- P1.04-003 The International Lung Screen Trial: A Multi-Center Study to Evaluate LDCT Screening Selection Criteria and Nodule Management (2017) (0)
- Screening behaviour of women in the ARTISTIC trial (2014) (0)
- Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort (2022) (0)
- Abstract Risk factors for lung cancer in never-smokers in Australia (2021) (0)
- The Indigenous Australian HPV Cohort Study 2; continuation 5 to 10 years: Study Protocol (Preprint) (2022) (0)
- Hide and Seek with Hereditary Cancer: Evaluating a Theory Grounded Approach to Implementing Systems Change to Appropriately Detect and Refer Lynch Syndrome Patients (2017) (0)
- Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study. (2023) (0)
- Abstract 2283: Population-level relevance of lifestyle-related risk factors for pancreatic cancer in Australia (2017) (0)
- Keynote Speakers (2021) (0)
- OA19.01 Prospective Study of Lung Cancer Screening Criteria: USPSTF2013 vs PLCOm2012 – International Lung Screening Trial (ILST) Results (2021) (0)
- Erratum to: The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England (2013) (0)
- HPV mRNA testing in cervical cancer screening - Authors' reply. (2022) (0)
- 778Risk of 27 cancer types in relation to tobacco smoking: cohort study involving 229,028 Australians (2021) (0)
- Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals (2022) (0)
- Reflections on the life and career of Professor Dame Valerie Beral AC DBE FRS FRCOG FMedSci (1943–2022) (2023) (0)
- Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort (2023) (0)
- Standard checklist for reporting studies of diagnostic accuracy (2014) (0)
- Abstract 2280: Burden of lung cancer in Australia avoidable by modifications to lifestyle-related risk factors (2017) (0)
- Defending the group from the terror within (2001) (0)
- Accurate categorisation of menopausal status for research studies: a step-by-step guide and detailed algorithm considering age, self-reported menopause and factors potentially masking the occurrence of menopause (2022) (0)
- A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions (2022) (0)
- Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes (2022) (0)
- CHANGES IN CANCER MORTALITY AND INCIDENCE IN AUSTRALIA 1987-2007 (2013) (0)
- The future burden of oesophageal and stomach cancers attributable to modifiable behaviours in Australia: a pooled cohort study (2022) (0)
- Author's response to reviews Title:Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money? A cost-utility analysis in a country with an existing school-girl program Authors: (2014) (0)
This paper list is powered by the following services:
Other Resources About Karen Canfell
What Schools Are Affiliated With Karen Canfell?
Karen Canfell is affiliated with the following schools:
